Trial Profile
A Phase III trial for F351 in China
Planning
Phase of Trial:
Phase III
Latest Information Update: 09 Oct 2018
At a glance
- Drugs Hydronidone (Primary)
- Indications Hepatic fibrosis; Renal fibrosis
- Focus Therapeutic Use
- 09 Oct 2018 New trial record